C12N 2506/094
From keratinocytes
Official title: from keratinocytes
C12N2506/094 (From keratinocytes) appears on 30 US grants and 56 published applications in this corpus.
Search patents in C12N- Granted patents
- 30
- Published applications
- 56
- Assignees
- 18
- Inventors
- 50
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 2 |
| 2012 | 0 | 4 |
| 2013 | 0 | 3 |
| 2014 | 0 | 2 |
| 2015 | 2 | 5 |
| 2016 | 4 | 5 |
| 2017 | 4 | 8 |
| 2018 | 6 | 5 |
| 2019 | 5 | 4 |
| 2020 | 3 | 3 |
| 2021 | 1 | 2 |
| 2022 | 0 | 2 |
| 2023 | 0 | 2 |
| 2024 | 2 | 2 |
| 2025 | 2 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for reprogramming cells and uses thereof12 May 2026US 12,624,342 B2Genesis Technologies Limited
- Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders20 May 2025US 12,305,195 B2University of Rochester
- Induction of pluripotent cells14 Jan 2025US 12,195,762 B2The Scripps Research Institute
- Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders29 Oct 2024US 12,129,484 B2University of Rochester
- Methods for reprogramming cells and uses thereof2 Jul 2024US 12,024,722 B2Genesis Technologies Limited
- Method for producing three-dimensionally cultered skin model comprising hair follicle structure using fibroblasts and three-dimensionally cultered skin model produced thereby20 Aug 2026US 2026/0242727 A1Tego Science Inc.
- Induction of pluripotent cells1 May 2025US 2025/0136948 A1The Scripps Research Institute
- Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders16 Jan 2025US 2025/0019653 A1University of Rochester
- A skin substitute composition and methods of producing and using the same7 Nov 2024US 2024/0366681 A1Triovance Holding LLC
- Methods for reprogramming cells and uses thereof17 Oct 2024US 2024/0344037 A1Genesis Technologies Limited
Most cited
By later US patents
- Induction of pluripotent cells14US 9,005,968 B2The Scripps Research Institute · 2015
- Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders12US 10,450,546 B2University of Rochester · 2019
- Cells prepared by transient transfection and methods of use thereof11US 10,155,038 B2Yale University · 2018
- Generation of pluripotent stem cells using recombinant proteins9US 9,068,170 B2The Scripps Research Institute · 2015
- Chemical approaches for generation of induced pluripotent stem cells9US 9,394,524 B2The Scripps Research Institute · 2016